Cancer research (imbcr.org) (imbcr.org)
cancer research
good_news_from_israel_890x1002

Exciting new development in cancer research targets malignant cells; US FDA has approved Israel TEVA’s Leukemia treatment; Zebra Medical Vision uses Artificial Intelligence to analyze results of medical scans, and much more.

ISRAEL’S MEDICAL ACHIEVEMENTS

New target for cancer treatments

Researchers at Israel’s Bar Ilan University have discovered a new enzyme called FerT, which exists only in the energy-generating mitochondria of cancer cells. When the enzyme was targeted in lab tests, the malignant cells were unable to produce energy and died.

Israeli Scientists Discover New Enzyme to Destroy in Metatastic Cancer Cells

US approval for Leukemia treatment

Following a Priority Review, the US FDA has approved Israel TEVA’s Leukemia treatment, TRISENOX® (arsenic trioxidec). Trisenox is to be used in combination with tretinoin for treatment of recently-diagnosed low-risk adults with acute promyelocytic leukemia (APL).

FDA Approves Teva Leukemia Treatment

Lymphoma treatment approved

I reported previously (3rd Sep) on the US takeover of Israeli biotech Kite for $12 billion. The US FDA has now approved Kite’s Yescarta treatment for adults with relapsed or refractory large B-cell lymphoma. The treatment uses Israeli-developed CAR-T therapy from the patient’s own T-cells.
http://www.jns.org/news-briefs/2017/10/20/israeli-developed-breakthrough-cancer-drug-receives-fda-approval

Stem cell treatment inhibits cancer

I’ve reported previously (18 times) on Israeli biotech Pluristem’s PLX stem cell treatment for many life-threatening conditions. Recent lab trials with modified PLX cells showed significant inhibitory effect on various lines of breast, colorectal, kidney, liver, lung, muscle and skin cancers.
http://www.pluristem.com/wp-content/uploads/2018/01/PLX_Cancer_Publication_final_isa.pdf
https://www.nature.com/articles/s41598-017-18428-1

Successful trials of implant to prevent OAB

I reported previously (July 2016) that the minimally invasive RENOVA leg implant from Israel’s BlueWind to treat Overactive Bladder (OAB) had been granted European approval. Recent trials show that device gave over 50% improvement to 71% of participants.
https://www.prnewswire.com/news-releases/bluewind-medical-announces-the-publication-of-breakthrough-results-for-bluewind-renova-implantable-tibial-nerve-neuromodulator-668016233.html
http://www.bluewindmedical.com/products

Creator Award for MyMDBand

I featured previously (twice) the Israeli-developed MyMDBand QR-coded wristband that provides paramedics with a patient’s vital medical data. Israeli Asaf Luxembourg, just won a WeWork Creator Award for it. United Hatzalah have distributed thousands of MyMDBands to the elderly.
http://www.jpost.com/Blogs/Israel-Rescues/That-Time-When-We-Do-Well-By-Doing-Good-510927

Analyze your scan for $1

I featured previously (9 times) Israeli startup Zebra Medical Vision which uses Artificial Intelligence to analyze the results of medical scans. Zebra is offering all its algorithms for $1 per scan. Now all hospitals can afford to test patients for osteoporosis, cardiac disease, liver disease, early cancer etc. https://www.cnbc.com/2017/10/27/zebra-medical-vision-is-using-ai-to-detect-cancer-before-humans-can-for-1.html

Click HERE for this week’s Good News from Israel.